
Dr. Kunal Goyal
Hematologist, Bone Marrow Transplant & Cellular Therapy Specialist
MD, DM Clinical Hematology Haemato-Oncologist, BMT & CAR-T Specialist, ex-TATA ACTREC
Dr. Kunal Goyal is a highly accomplished Clinical Hematologist and Haemato-Oncologist with over 6 years of specialised experience in advanced hematological care. He currently serves as the Consultant and Head of Hemato-Oncology at the Indian Cancer Treatment Centre (ICTC) and is widely recognised for his expertise in bone marrow transplantation, CAR-T cell therapy, and cellular therapies. Dr. Goyal has performed over 200 bone marrow transplants and has played a key role in CAR-T cell therapy trials at Tata Memorial Centre (TATA ACTREC). His work at one of India’s most advanced cancer institutes has given him extensive exposure to complex hematological malignancies, including leukemia, lymphoma, and other high-risk blood disorders. Academically, Dr. Goyal holds an MBBS, MD, and DM in Clinical Hematology from IHTM Kolkata. He further completed a fellowship in Bone Marrow Transplantation and Cellular Therapies from Tata Memorial Centre, where he gained hands-on expertise in cutting-edge treatments such as CAR-T cell therapy and advanced stem cell transplantation. Dr. Goyal is known for achieving a major milestone by successfully performing the first-ever CAR-T cell therapy in a private healthcare setup in Navi Mumbai, marking a significant advancement in accessible cellular therapy in the region. His work reflects a strong commitment to bringing globally advanced treatments closer to patients. Clinically, Dr. Goyal specializes in the management of leukemia, lymphoma, myelodysplastic syndromes, coagulation disorders, and complex hematological conditions. His expertise spans autologous and allogeneic bone marrow transplantation, CAR-T cell therapy, and innovative cellular therapies designed for treatment-resistant and high-risk cases. In addition to his clinical excellence, Dr. Goyal is actively involved in academic research and medical education. He has authored and contributed to research on leukemia, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), pediatric CML, and CAR-T cell therapies. His ongoing publications in reputed medical journals contribute valuable insights into advanced hematological and cellular therapies. Dr. Goyal is admired for his optimistic and patient-centric approach to care, guided by his personal mantra: “There is always hope beyond what you see.” Through innovation, precision, and compassion, he continues to transform the landscape of hematology and advanced cancer care at ICTC.
There is always hope beyond what you see. My philosophy of care is rooted in innovation, scientific precision, and unwavering optimism. I believe that advanced hematological diseases require cutting-edge therapies delivered with empathy, transparency, and strong patient support. Every treatment plan is designed to maximise outcomes while preserving quality of life.